Efficacy of Pectoral Nerve Block for Breast Reduction Surgery

April 26, 2019 updated by: Arzu Karaveli, Antalya Training and Research Hospital

Comparison of The Effects of Pectoral Nerve Block and Local Infiltration Anesthesia on Postoperative Analgesia for Breast Reduction Surgery

The purpose of the study is to evaluate the efficacy of PECS block applied to patients undergoing bilateral breast reduction surgery on postoperative analgesia compared to local infiltration anesthesia.

Study Overview

Detailed Description

Pectoral nerve block (PECS block) has been developed as an alternative to thoracic paravertebral and/or thoracic epidural blocks in recent years. It is frequently applied for postoperative analgesia especially in breast cancer surgery and subpectoral breast prosthesis.

Study Type

Observational

Enrollment (Actual)

53

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Antalya, Turkey, 07100
        • Antalya Training and Research Hospital, Department of Anesthesiology and Reanimation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

The study included patients with ASA I-II, 18-65 years old, with a BMI ≤ 40 kg/m2 and undergoing elective breast reduction operation under general anesthesia.

Description

Inclusion Criteria:

  • American Society of Anesthesiology (ASA) I-II
  • body mass index (BMI) ≤40 kg/m2
  • elective bilateral breast reduction surgery

Exclusion Criteria:

  • declining to give written informed consent
  • ASA III and above
  • under 18 years of age or over 65 years of age
  • history of allergy against to the local anesthetics,
  • controendication of peripheral block or local anesthetic infiltration (local infection, coagulopathy, etc.)
  • history of breast surgery
  • treatment due to psychiatric disorder
  • history of treatment for a chronic pain
  • history of nerve blocks in order to treat postoperative pain

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
PECS group
Preoperative bilateral PECS I + PECS II Pecs block performed by anaesthetist using ultrasound guidance in plane approach
Pecs block performed using ultrasound guidance
Other Names:
  • Regional anesthesia in breast surgery
Control group
Bilateral local anesthesia infiltration Local infiltration anesthesia performed by surgeon during the operation
Local infiltration anesthesia performed during the operation
Other Names:
  • Regional anesthesia in breast surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
postoperative visual analog scale (VAS) score
Time Frame: postoperative 0, 1, 3, 6, 9, and 12 hours
Postoperative pain assessment will be performed using the VAS score (VAS 0 = no pain, VAS 10 = most severe pain possible). The VAS scores will be recorded at postoperative 0, 1, 3, 6, 9, and 12 hours.
postoperative 0, 1, 3, 6, 9, and 12 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
analgesia consumption
Time Frame: during the surgery
intraoperative
during the surgery
analgesia consumption
Time Frame: 12 hours
postoperative
12 hours
length of hospital
Time Frame: 4 days
recorded at the following time after surgery
4 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Arzu Karaveli, Netherlands: Ministry of Health, Welfare and Sports

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2017

Primary Completion (Actual)

March 1, 2018

Study Completion (Actual)

May 1, 2018

Study Registration Dates

First Submitted

December 18, 2018

First Submitted That Met QC Criteria

February 26, 2019

First Posted (Actual)

February 28, 2019

Study Record Updates

Last Update Posted (Actual)

April 30, 2019

Last Update Submitted That Met QC Criteria

April 26, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Surgery

Clinical Trials on PECS group

3
Subscribe